Company Filing History:
Years Active: 2021-2022
Title: Innovations and Contributions of Inventor Li Li
Introduction
Li Li is a notable inventor based in Xiamen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific kinases associated with tumor growth and metastasis. With a total of 3 patents, his work is recognized for its potential impact on cancer treatment.
Latest Patents
Li Li's latest patents include innovative compounds and methods that have promising applications in medicine. One of his patents focuses on substituted penta-fused hexa-heterocyclic compounds, which exhibit selective inhibition for PIKfyve kinase. This invention includes a preparation method, a pharmaceutical composition, and the use of these compounds in the manufacture of medicaments aimed at preventing or treating diseases associated with PIKfyve, particularly in the context of tumor growth and metastasis. Another significant patent involves a substituted aryl ether compound, detailing its preparation method, pharmaceutical composition, and its application in the manufacture of medicaments for tumor treatment.
Career Highlights
Throughout his career, Li Li has worked with esteemed institutions such as Xiamen University and Hongyun Biotech Co., Ltd. His research and innovations have contributed to advancements in pharmaceutical sciences, particularly in the development of targeted therapies for cancer.
Collaborations
Li Li has collaborated with notable colleagues, including Xianming Deng and Xihuan Sun, who have contributed to his research endeavors. Their combined expertise has furthered the development of innovative solutions in the pharmaceutical field.
Conclusion
Li Li's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and demonstrates the importance of innovation in medicine.